Cu(II)ATSM: Clinical Trials

3 trials of Cu(II)ATSM, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 unknown, 1 completed. 3 Phase 2, 1 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 23Unknown 2, Completed 1
Phase 11Unknown 1
Phase 31Unknown 1

Follow Cu(II)ATSM: new trials by email Literature Review of Cu(II)ATSM trials Research Report on Cu(II)ATSM

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Treatment Continuation Study for Patients With ALS/MND Who Completed Study CMD-2019-001
Cu(II)ATSM - Amyotrophic Lateral Sclerosis
Phase 2CompletedCollaborative Medicinal Development Pty Limited552020-03-192022-02-17
CuATSM Compared With Placebo for Treatment of ALS/MND
Cu(II)ATSM, Placebos - Amyotrophic Lateral Sclerosis
Phase 2 / Phase 3UnknownCollaborative Medicinal Development Pty Limited802019-09-302019-11-06
ALS Treatment Extension Study
Cu(II)ATSM - Amyotrophic Lateral Sclerosis
Phase 1 / Phase 2UnknownCollaborative Medicinal Development Pty Limited282018-01-182022-02-17

Conditions studied

Amyotrophic Lateral Sclerosis (3)

Sponsors

Collaborative Medicinal Development Pty Limited (3)

Countries

Australia (3)

Top investigators

Dominic Rowe, MD (3)